Fetal fraction and noninvasive prenatal testing: What clinicians need to know.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 155, doi. 10.1002/pd.5620
- By:
- Publication type:
- Article
Works matching IS 01973851 AND DT 2020 AND VI 40 AND IP 2
Results: 17
1
2
Caution is needed in characterizing fetal posterior fossa malformations with transabdominal ultrasound.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 282, doi. 10.1002/pd.5602
- Publication type:
- Article
3
Issue Information.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 153, doi. 10.1002/pd.5482
- Publication type:
- Article
4
Exome sequencing for perinatal phenotypes: The significance of deep phenotyping.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 260, doi. 10.1002/pd.5616
- By:
- Publication type:
- Article
5
Maceration determines diagnostic yield of fetal and neonatal whole body post‐mortem ultrasound.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 232, doi. 10.1002/pd.5615
- By:
- Publication type:
- Article
6
Prenatal cerebral imaging features of a new syndromic entity related to KIAA1109 pathogenic variants mimicking tubulinopathy.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 276, doi. 10.1002/pd.5589
- By:
- Publication type:
- Article
7
In fetuses with congenital lung masses, decreased ventricular and atrioventricular valve dimensions are associated with lesion size and clinical outcome.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 206, doi. 10.1002/pd.5612
- By:
- Publication type:
- Article
8
Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 179, doi. 10.1002/pd.5609
- By:
- Publication type:
- Article
9
Cell‐free DNA for Down syndrome screening in obese women: Is it a cost‐effective strategy?
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 173, doi. 10.1002/pd.5605
- By:
- Publication type:
- Article
10
Prevalence of mosaicism in uncultured chorionic villus samples after chromosomal microarray and clinical outcome in pregnancies affected by confined placental mosaicism.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 244, doi. 10.1002/pd.5584
- By:
- Publication type:
- Article
11
High risk for carriers of de novo balanced structural chromosomal aberrations in prenatal diagnosis: Latin America data.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 274, doi. 10.1002/pd.5600
- By:
- Publication type:
- Article
12
Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 197, doi. 10.1002/pd.5590
- By:
- Publication type:
- Article
13
The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell‐free DNA screening.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 185, doi. 10.1002/pd.5583
- By:
- Publication type:
- Article
14
Prenatal diagnosis and postnatal outcome of anterior urethral anomalies.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 191, doi. 10.1002/pd.5582
- By:
- Publication type:
- Article
15
Improving fetal congenital heart disease screening using a checklist‐based approach.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 223, doi. 10.1002/pd.5581
- By:
- Publication type:
- Article
16
Cerebral blood flow dynamic in foetuses with hypoplastic left heart syndrome: Incremental value of the first segment of the anterior cerebral artery over the middle cerebral artery?
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 216, doi. 10.1002/pd.5564
- By:
- Publication type:
- Article
17
A 2‐year review of publicly funded cell‐free DNA screening in Ontario: utilization and adherence to funding criteria.
- Published in:
- Prenatal Diagnosis, 2020, v. 40, n. 2, p. 164, doi. 10.1002/pd.5563
- By:
- Publication type:
- Article